Related Experiment Videos

A clinical tool to predict failed response to therapy in children with severe pneumonia

Manju Mamtani1, Archana Patel, Patricia L Hibberd

  • 1Lata Medical Research Foundation, Nagpur, India.

Pediatric Pulmonology
|March 31, 2009
PubMed

Insights

Predicting treatment failure in severe childhood pneumonia is crucial. A new simple clinical tool using age and respiratory rate can accurately identify children at risk, aiding timely interventions where advanced diagnostics are unavailable.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Clinical Medicine

Background:

  • Severe pneumonia in children under 5 is a significant health issue with high treatment failure rates (up to 20%).
  • Existing predictive tools like chest radiography and pulse oximetry are often inaccessible or unaffordable in resource-limited settings.
  • There is a critical need for simple, accurate, and inexpensive clinical tools to predict treatment failure in severe pneumonia.

Purpose of the Study:

  • To develop and validate a simple clinical tool for predicting treatment failure in children with severe pneumonia.
  • To identify key clinical predictors of treatment failure in this vulnerable population.

Main Methods:

  • Utilized data from 1702 children in the Amoxicillin Penicillin Pneumonia International Study (APPIS) trial.
  • Developed a predictive tool using multivariate logistic regression on a development sample (n=889).
  • Validated the tool on a separate validation sample (n=813).

Main Results:

  • The final clinical tool incorporates three predictors: child's age, excess age-specific respiratory rate at baseline, and at 24 hours of hospitalization.
  • The tool demonstrated predictive accuracies of 70% in the development sample and 66% in the validation sample.
  • The tool is presented as an easy-to-use nomogram for practical application.

Conclusions:

  • A simple clinical tool can effectively predict the likelihood of treatment failure in children with severe pneumonia.
  • The tool relies on easily measurable and inexpensive clinical features, making it suitable for resource-limited settings.
  • This nomogram provides a valuable method for early identification of children at risk of treatment failure, enabling prompt management.

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...